SCHEMBL75274

SCHEMBL75274

CCCCCCCCCCCCCCCCCC(N)CC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G1B P04054 1/20 0.58
PLA2G2A P14555 1/20 0.58
OPRM1 P35372 1/20 0.55
S1PR2 O95136 5/20 0.52
S1PR1 P21453 5/20 0.52
S1PR3 Q99500 5/20 0.52
S1PR4 O95977 4/20 0.52
SPHK1 Q9NYA1 2/20 0.50
CYP2D6 P10635 2/20 0.46
LMNA P02545 2/20 0.46
GMNN O75496 1/20 0.46
POLB P06746 1/20 0.46
THPO P40225 1/20 0.46
MTOR P42345 1/20 0.46
BLM P54132 1/20 0.46
KDM4E B2RXH2 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8980887 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL118198 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL6898957 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL6559841 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL4805519 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL8980631 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL24530563 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL13262906 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL14043625 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL37305 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1810 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4314162-B1 EMULSIFYING COMPOSITION FOR BITUMENS VALOCHEM (FR) 2025-06-18 EP claimed
US-11780739-B2 Method for producing iron oxide magnetic particles, and iron oxide magnetic materials prepared thereby ZTI BIOSCIENCES CO., LTD. (KR) 2023-10-10 US claimed
US-20210317005-A1 METHOD FOR PRODUCING IRON OXIDE MAGNETIC PARTICLES, AND IRON OXIDE MAGNETIC MATERIALS PREPARED THEREBY ZTI BIOSCIENCES CO., LTD. (KR) 2021-10-14 US claimed
EP-2838501-B1 WATER RESISTANT COMPOSITIONS CONTAINING A HETEROCYCLIC COMPOUND AND A COMPOUND HAVING AT LEAST ONE FUNCTIONAL GROUP CHOSEN FROM AN AMINO GROUP AND A HYDROXYL GROUP L'ORÉAL (FR) 2018-02-28 EP claimed
EP-2838501-A2 WATER RESISTANT COMPOSITIONS CONTAINING A HETEROCYCLIC COMPOUND AND A COMPOUND HAVING AT LEAST ONE FUNCTIONAL GROUP CHOSEN FROM AN AMINO GROUP AND A HYDROXYL GROUP L'Oréal (FR) 2015-02-25 EP claimed
US-8815985-B2 Curable composition KANEKA CORPORATION (JP) 2014-08-26 US claimed
WO-2013156385-A2 WATER RESISTANT COMPOSITIONS CONTAINING A HETEROCYCLIC COMPOUND AND A COMPOUND HAVING AT LEAST ONE FUNCTIONAL GROUP CHOSEN FROM AN AMINO GROUP AND A HYDROXYL GROUP L'OREAL (FR) 2013-10-24 WO claimed
US-20130272980-A1 WATER RESISTANT COMPOSITIONS CONTAINING A LACTONE COMPOUND AND AN AMINE COMPOUND L'ORéAL S.A. (FR) 2013-10-17 US claimed
CN-101489524-A Method and composition for permanently shaping hair PROCTER & GAMBLE (US) 2009-07-22 CN claimed
WO-2008081348-A2 METHOD AND COMPOSITION FOR PERMANENTLY SHAPING HAIR THE PROCTER & GAMBLE COMPANY (US) 2008-07-10 WO claimed
WO-2007075681-A1 CHEMICALLY-ENHANCED MECHANICAL TREATMENT OF WATER HERCULES INCORPORATED (US) 2007-07-05 WO claimed
US-6897281-B2 Breathable polyurethanes, blends, and articles NOVEON IP HOLDINGS CORP. (US) 2005-05-24 US claimed
EP-0886551-B1 STABILITY CONTROL AGENT COMPOSITION FOR POLYOLEFIN FOAM KNAUS DENNIS A (US) 2004-08-04 EP claimed
CN-1499952-A Compositions comprising heteropolymers and methods of use thereof 欧莱雅股份有限公司 2004-05-26 CN claimed
EP-1392232-A2 COSMETIC COMPOSITIONS CONTAINING HETEROPOLYMERS AND OIL-SOLUBLE CATIONIC SURFACTANTS AND METHODS OF USING SAME l'Oreal SA (FR) 2004-03-03 EP claimed
EP-1339374-A2 COMPOSITIONS CONTAINING HETEROPOLYMERS AND METHODS OF USING SAME l'Oreal SA (FR) 2003-09-03 EP claimed
US-20030082126-A9 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same L'OREAL S.A. (FR) 2003-05-01 US claimed
US-20020122781-A1 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same PINZON CARLOS O (US) 2002-09-05 US claimed
WO-2002047620-A2 COMPOSITIONS CONTAINING HETEROPOLYMERS AND METHODS OF USING SAME L'OREAL SA (FR) 2002-06-20 WO claimed
WO-2002047658-A2 COSMETIC COMPOSITIONS CONTAINING HETEROPOLYMERS AND OIL-SOLUBLE CATIONIC SURFACTANTS AND METHODS OF USING SAME L'OREAL SA (FR) 2002-06-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020122781-A1 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same SYMPK, CUTA, LSS PLA2G1B 1052/4885PLA2G2A 1061/4885OPRM1 3701/4885
US-20130272980-A1 WATER RESISTANT COMPOSITIONS CONTAINING A LACTONE COMPOUND AND AN AMINE COMPOUND SRM, KRT18, SMS PLA2G1B 2892/4885PLA2G2A 1596/4885OPRM1 4652/4885
US-20030082126-A9 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same SYMPK, CUTA, LSS PLA2G1B 1052/4885PLA2G2A 1061/4885OPRM1 3701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.